Büller HR - Search Results

1

Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis.

Schünemann HJ, Ventresca M, Crowther M, Briel M, Zhou Q, Noble S, Macbeth F, Griffiths G, Garcia D, Lyman GH, Di Nisio M, Iorio A, Mbuagbaw L, Neumann I, van Es N, Brouwers M, Guyatt G, Streiff MB, Marcucci M, Baldeh T, Florez ID, Alma OG, Solh Z, Bossuyt PM, Kahale LA, Ageno W, Bozas G, Büller HR, Lebeau B, Lecumberri R, Loprinzi C, McBane R, Sideras K, Maraveyas A, Pelzer U, Perry J, Klerk C, Agnelli G, Akl EA. Schünemann HJ, et al. Among authors: buller hr. Lancet Haematol. 2020 Oct;7(10):e746-e755. doi: 10.1016/S2352-3026(20)30293-3. Lancet Haematol. 2020. PMID: 32976752

2

Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ. Bijsterveld NR, et al. Among authors: buller hr. J Am Coll Cardiol. 2002 Mar 6;39(5):811-7. doi: 10.1016/s0735-1097(01)01825-3. J Am Coll Cardiol. 2002. PMID: 11869846 Free article. Clinical Trial.

3

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, Büller HR. Strebel N, et al. Among authors: buller hr. Arch Intern Med. 2002 Jul 8;162(13):1451-6. doi: 10.1001/archinte.162.13.1451. Arch Intern Med. 2002. PMID: 12090880 Review.

4

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.

Klerk CP, Smorenburg SM, Büller HR. Klerk CP, et al. Among authors: buller hr. Arch Intern Med. 2003 Sep 8;163(16):1913-21. doi: 10.1001/archinte.163.16.1913. Arch Intern Med. 2003. PMID: 12963564 Review.

5

Antithrombotic therapy and cancer.

Di Nisio M, Squizzato A, Klerk CP, Richel DJ, Büller HR. Di Nisio M, et al. Among authors: buller hr. Curr Opin Hematol. 2004 May;11(3):187-91. doi: 10.1097/01.moh.0000130317.18163.83. Curr Opin Hematol. 2004. PMID: 15257019 Review.

6

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Büller HR, et al. Chest. 2004 Sep;126(3 Suppl):401S-428S. doi: 10.1378/chest.126.3_suppl.401S. Chest. 2004. PMID: 15383479 Review.

7

The effect of low molecular weight heparin on survival in patients with advanced malignancy.

Klerk CP, Smorenburg SM, Otten HM, Lensing AW, Prins MH, Piovella F, Prandoni P, Bos MM, Richel DJ, van Tienhoven G, Büller HR. Klerk CP, et al. Among authors: buller hr. J Clin Oncol. 2005 Apr 1;23(10):2130-5. doi: 10.1200/JCO.2005.03.134. Epub 2005 Feb 7. J Clin Oncol. 2005. PMID: 15699479 Clinical Trial.

8

Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review.

Wichers IM, Di Nisio M, Büller HR, Middeldorp S. Wichers IM, et al. Among authors: buller hr. Haematologica. 2005 May;90(5):672-7. Haematologica. 2005. PMID: 15921382 Review.

9

Direct thrombin inhibitors.

Di Nisio M, Middeldorp S, Büller HR. Di Nisio M, et al. Among authors: buller hr. N Engl J Med. 2005 Sep 8;353(10):1028-40. doi: 10.1056/NEJMra044440. N Engl J Med. 2005. PMID: 16148288 No abstract available.

10

Plasma cytokine and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular weight heparin administration.

Di Nisio M, Niers TM, Reitsma PH, Buller HR. Di Nisio M, et al. Among authors: buller hr. Cancer. 2005 Nov 15;104(10):2275-81. doi: 10.1002/cncr.21485. Cancer. 2005. PMID: 16216004 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

733 results

Search Page